![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Metabolic, Bone, Renal, Inflammatory and Lipodystrophic Marker Analysis in INROADS, a Multicenter, Single-Arm, Open-Label Study of a Once-Daily Nucleoside/tide-Sparing Regimen of Etravirine (ETR) and Darunavir/Ritonavir (DRV/r) as Dual Therapy in Early Treatment-Experienced Subjects
|
|
|
Reported by Jules Levin
IDSA 2013 Oct 2-6 San Francisco, CA
Moti Ramgopal,1 Fritz Bredeek,2 Joseph Gathe,3 Robert Ryan,4 Bruce Coate,4 David Anderson5
1Midway Immunology and Research Center, Ft. Pierce, Florida, USA; 2Metropolis Medical, San Francisco, California, USA; 3Therapeutic Concepts, Houston, Texas, USA; 4Janssen Research & Development, Titusville, New Jersey, USA; 5Janssen Services, LLC, Titusville, New Jersey, USA
![ID1.gif](../images/101113/101113-2/ID1.gif)
![ID2.gif](../images/101113/101113-2/ID2.gif)
![ID3.gif](../images/101113/101113-2/ID3.gif)
![ID4.gif](../images/101113/101113-2/ID4.gif)
![ID5.gif](../images/101113/101113-2/ID5.gif)
![ID6.gif](../images/101113/101113-2/ID6.gif)
![ID7.gif](../images/101113/101113-2/ID7.gif)
![ID8.gif](../images/101113/101113-2/ID8.gif)
![ID9.gif](../images/101113/101113-2/ID9.gif)
![ID10.gif](../images/101113/101113-2/ID10.gif)
![ID11.gif](../images/101113/101113-2/ID11.gif)
![ID12.gif](../images/101113/101113-2/ID12.gif)
![ID13.gif](../images/101113/101113-2/ID13.gif)
![ID14.gif](../images/101113/101113-2/ID14.gif)
![ID15.gif](../images/101113/101113-2/ID15.gif)
![ID16.gif](../images/101113/101113-2/ID16.gif)
![ID17.gif](../images/101113/101113-2/ID17.gif)
![ID18.gif](../images/101113/101113-2/ID18.gif)
![ID19.gif](../images/101113/101113-2/ID19.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|